Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis

OBJECTIVE: This study describes treatment patterns, healthcare resource utilization (HCRU), and costs associated with persistence, switching, and dosing of branded celecoxib in osteoarthritis (OA) patients. METHODS: This retrospective claims database analysis used MarketScan(®) Commercial Claims and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clinicoecon Outcomes Res
Asıl Yazarlar: Johnson, Courtney, Stephens, Jennifer, Walker, Christopher, Cappelleri, Joseph C, Shelbaya, Ahmed
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982435/
https://ncbi.nlm.nih.gov/pubmed/32021340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S199145
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller